Skip to main content

 38KF | pdb_000038kf

Crystal Structure of Chalcone Isomerase from Medicago Truncatula Complexed with Phloretin


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 
    0.249 (Depositor), 0.251 (DCC) 
  • R-Value Work: 
    0.220 (Depositor), 0.221 (DCC) 
  • R-Value Observed: 
    0.221 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 38KF

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history. 

Literature

Snapshots From the Catalytic Landscape of Chalcone Isomerase.

Burke, J.R., Rangel, M.A., Vasquez Meza, V.I., Mims, H.N., Darko, T.O., Ixcoy, K., Rivera, A.R., Zhang, J., Wolf-Saxon, E.R., Moorman, C.C.

(2026) Plant Direct 10: e70200-e70200

  • DOI: https://doi.org/10.1002/pld3.70200
  • Primary Citation Related Structures: 
    38KF

  • PubMed Abstract: 

    Chalcone isomerase (CHI) catalyzes the cyclization of three-ring scaffolds of flavonoids, a class of plant-based natural products important for nutrition and disease prevention. A persistent question has been whether the enzyme uses protein dynamics to facilitate conformational rearrangements of substrates within the active site. To help resolve this question, CHI from Medicago truncatula was crystallized with phloretin, a flexible substrate analogue that cannot undergo cyclization, and solved to 2.0-Å resolution. The crystal structure possesses eight protein molecules per asymmetric unit, revealing different active site conformations that accommodate different bound conformers of phloretin. Together, the structural snapshots depict a series of coordinated, dynamic chemical interactions that lower barriers to substrate rearrangements approaching bond formation. Differential scanning fluorimetry combined with mutational analysis and enzyme kinetics further confirms that phloretin binds to the enzyme active site, and that it acts as a competitive inhibitor of CHI. Together, these findings answer outstanding questions about the flexibility and dynamics of CHI catalysis, information that may be useful for future biosynthetic design and enzyme engineering goals. Overall, this work supports a catalytic model in which the CHI enzyme operates as a dynamic ensemble of structures necessary to facilitate catalytic substrate rearrangements.


  • Organizational Affiliation: 
    • Department of Chemistry and Biochemistry California State University San Bernardino San Bernardino California USA.

Macromolecule Content 

  • Total Structure Weight: 197.1 kDa 
  • Atom Count: 13,416 
  • Modeled Residue Count: 1,686 
  • Deposited Residue Count: 1,792 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Chalcone-flavonone isomerase family protein
A, B, C, D, E
A, B, C, D, E, F, G, H
224Medicago truncatulaMutation(s): 0 
Gene Names: 11445536, MTR_1g115870
UniProt
Find proteins for B7FJK3 (Medicago truncatula)
Explore B7FJK3 
Go to UniProtKB:  B7FJK3
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupB7FJK3
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
G50
(Subject of Investigation/LOI)

Query on G50



Download:Ideal Coordinates CCD File
I [auth A]
J [auth B]
K [auth C]
L [auth D]
M [auth E]
I [auth A],
J [auth B],
K [auth C],
L [auth D],
M [auth E],
N [auth F],
O [auth G],
P [auth H]
3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE
C15 H14 O5
VGEREEWJJVICBM-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free:  0.249 (Depositor), 0.251 (DCC) 
  • R-Value Work:  0.220 (Depositor), 0.221 (DCC) 
  • R-Value Observed: 0.221 (Depositor) 
Space Group: P 32
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 84.86α = 90
b = 84.86β = 90
c = 220.359γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
PHENIXrefinement
MOSFLMdata reduction
SCALAdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data

  • Released Date: 2026-09-16 
  • Deposition Author(s): Burke, J.R.

Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesR16GM159693

Revision History  (Full details and data files)

  • Version 1.0: 2026-09-16
    Type: Initial release
  • Version 1.1: 2026-10-28
    Changes: Database references